Abstract-2,4-Disubstituted quinolines with additional substituents in positions 5-8 have been found to have anthelmintic properties. A number of 2,4-dimethoxy-6-or 8-arylquinolines have potent activity against the sheep nematode Haemonchus contortus, with LD 99 values of the same order of magnitude as levamisole. These arylquinolines maintain their activity against levamisole, ivermectin and thiabendazole resistant strains of H contortus.
Parasitic nematode infections are a continuing threat in both human and animal medicine. The most commonly used classes of drugs to treat such infections are the benzimidazoles such as thiabendazole 1, imidazothiazoles such as levamisole 2, and avermectins (obtained from the fermentation products of Streptomyces avermitilis). There is evidence of emerging resistance to some drugs in the developing world, 1 and in some areas with high agricultural dependence multiple resistance to all of the major drug classes is appearing in livestock.
2 Alternatives to these classes of drug are now being sought. We recently published a concise synthesis of the prenylquinoline alkaloid atanine, 3, 3 shown to be active against larval stages of the trematode parasite Schistosoma mansoni, the cause of schistosomiasis (bilharzia), a major health issue in developing countries. 4 As part of our program of synthesis and testing of novel atanine analogues, we synthesized a number of intermediate trisubstituted quinolines with substituents in ring positions 5-8. Tests against S. mansoni larval stages and the model nematode C. elegans revealed that some of these intermediates exhibited anti-nematode activity, differing from the pattern of activity against schistosomes. From these early biological results, we became interested in aryl-substituted quinolines, and so we set out to investigate the synthesis of these novel 2,4-dimethoxy aryl-substituted quinolines by exploring the Suzuki coupling of 5-, 6-, 7-or 8-bromoquinoline intermediates.
Substituted-2,4-dimethoxyquinolines were synthesized by condensation/cyclization of the appropriate substituted aniline 4 with malonic acid and phosphoryl chloride to give the 2,4-dichloroquinoline 5, followed by displacement by methoxide ion to give the required quinoline 6 (Scheme 1). For our proposed synthesis of arylquinolines, the bromoquinoline precursors were synthesized. Cyclization of 3-bromoaniline gave a mixture of the 5-and 7-bromoquinolines, which were separable by column chromatography. The bromo-2,4-dimethoxy-quinolines 7 were then coupled to the required aryl groups under Suzuki conditions to yield the arylquinolines 8 (scheme 2). These proceeded in good yield, although it was observed that 8-bromoquinolines were much more sensitive, requiring stricter oxygen-free reaction conditions to give consistent yields. A number of 2,4-disubstituted quinolines (ca 80) were tested against the agriculturally important parasitic nematode Haemonchus contortus, using the commercial NemaTox larval development screen used for determining drug susceptibility. 9 It was observed that greater than 40% of these compounds exhibited nematocidal activity (LD 99 <100 µg/mL), with those exhibiting LD 99 better than 25 µg/mL shown in Table 1 . In particular, it appeared that 6-or 8-substituted 2,4-dimethoxyquinolines showed the greatest activity against H. contortus. Five compounds, including the arylquinolines 13-16, had LD 99 of 12.5 µg/mL or lower in this first screen, showing potential for useful antinematode activity. The LD 99 of compounds 15 and 16, 3.1 µg/mL, was of the same order as the commercial nematocides levamisole and closantel. These five most active compounds were resynthesized in gram quantities for further investigation. Table 2 , with activities of thiabendazole 1 and levamisole 2 for comparison. Of these compounds, 15 and 16 exhibited the greatest activity against susceptible strains of H. contortus (3.1µg/mL), comparable in potency to levamisole. 15 and 16 were also potent against the various drugresistant strains of H contortus, with even improved activity for 16; LD 99 1.6 µg/mL, against both the multiple-resistant Lawes strain and the ivermectin resistant CAVR strain. There is also evidence of activity against the important parasitic nematodes Trichostrongylus colubriformis and Ostertagia circumcincta.
In summary, we have prepared novel arylquinolines in good yields via Suzuki coupling of substituted bromoquinolines. We have demonstrated that a number of these quinolines, in particular the 6-arylquinolines 15, 16, show promising potency against susceptible and drug-resistant strains of an important nematode target, and represent a new class of anthelmintic compounds. There is obvious potential for lead optimization and further development to offer a new line of defence against drug-resistant parasitic nematode infections.
